2-(3-iodo-4-methoxyphenyl)ethan-1-ol | 1246457-10-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 2-(3-iodo-4-methoxyphenyl)ethan-1-ol
• 英文别名: 2-(3-iodo-4-methoxyphenyl)ethanol；2-(3-Iodo-4-methoxyphenyl)ethanol
• CAS: 1246457-10-2
• 化学式: C₉H₁₁IO₂
• 分子量: 278.09
• InChiKey: UDHJSISEGPTKFP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(3-iodo-4-methoxyphenyl)ethan-1-ol 在 4-二甲氨基吡啶 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 3-hydroxy-1-[2-(3-iodo-4-methoxyphenyl)ethyl]quinuclidin-1-ium 4-methylbenzenesulfonate
  参考文献：
  名称：

  碘化胆碱转运靶向示踪剂

  摘要：

  我们提出了一系列新颖的放射性碘示踪剂和潜在的疾病治疗学，伴随着胆碱转运蛋白的病理功能。与临床上当前使用的标有11 C或18 F的胆碱类似物不同，本文所述的碘化化合物可根据碘同位素选择，应用于正电子发射断层扫描，单光子发射计算机断层扫描以及潜在地用于治疗。而且，碘同位素的有利半衰期导致通过同位素交换反应的具有挑战性的合成要少得多。所描述的化合物中有六个是纳摩尔配体，最佳化合物的亲和力比胆碱高100倍。125的生物分布数据用I标记的人类前列腺癌（PC-3）小鼠配体显示了两种化合物，其生物分布特征优于[ 18 F]氟胆碱。

  DOI：

  10.1021/acs.jmedchem.0c01710
• 作为产物：
  描述：

  3-iodo-4-methoxyphenethyl acetate 在 potassium carbonate 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以100%的产率得到2-(3-iodo-4-methoxyphenyl)ethan-1-ol
  参考文献：
  名称：

  Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1

  摘要：

  The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR) of cancer cells, was found to be modulated by verapamil, through stimulation of GSH transport, leading to apoptosis of MRP1-overexpressing cells. In this study, various iodinated derivatives of verapamil were synthesized, including iodination on the B ring, known to be involved in verapamil cardiotoxicity, and assayed for the stimulation of GSH efflux by MRP1. The iodination, for nearly all compounds, led to a higher stimulation of GSH efflux. However, determination of concomitant cytotoxicity is also important for selecting the best compound, which was found to be 10-fold more potent than verapamil. This will then allow us to design original anti-cancer compounds which could specifically kill the resistant cancer cells. (C) 2010 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmc.2010.07.031

文献信息

• [EN] COMPOUND TARGETING NOREPINEPHRINE TRANSPORTER<br/>[FR] COMPOSÉ CIBLANT UN TRANSPORTEUR DE NORÉPINÉPHRINE
  申请人：UNIV WUERZBURG J MAXIMILIANS

  公开号：WO2020148154A1

  公开（公告）日：2020-07-23

  The invention concerns a compound according to following formula, wherein R1 is an F or an I residue.

  这项发明涉及一种化合物，其化学式如下，其中R1是F或I残基。
• COMPOUND TARGETING NOREPINEPHRINE TRANSPORTER
  申请人：Julius-Maximilians-Universität Würzburg

  公开号：EP3682906A1

  公开（公告）日：2020-07-22

  The invention concerns a compound according to following formula wherein R1 is a halogen residue.

  本发明涉及一种符合下式的化合物 其中 R1 为卤素残基。
• Compound Targeting Norepinephrine Transporter
  申请人：GUANGZHOU MIPHERE MEDICAL TECHNOLOGY CO., LTD.

  公开号：US20220096667A1

  公开（公告）日：2022-03-31

  A compound according to following formula can be prepared, where R1 is an F or I residue.
• Iodinated Choline Transport-Targeted Tracers
  作者：Pavel Švec、Zbyněk Nový、Jan Kučka、Miloš Petřík、Ondřej Sedláček、Martin Kuchař、Barbora Lišková、Martina Medvedíková、Kristýna Kolouchová、Ondřej Groborz、Lenka Loukotová、Rafał Ł. Konefał、Marián Hajdúch、Martin Hrubý

  DOI：10.1021/acs.jmedchem.0c01710

  日期：2020.12.24

  theranostics for diseases accompanied by pathological function of proteins involved in choline transport. Unlike choline analogues labeled with 11C or 18F that are currently used in the clinic, the iodinated compounds described herein are applicable in positron emission tomography, single-photon emission computed tomography, and potentially in therapy, depending on the iodine isotope selection. Moreover

  我们提出了一系列新颖的放射性碘示踪剂和潜在的疾病治疗学，伴随着胆碱转运蛋白的病理功能。与临床上当前使用的标有11 C或18 F的胆碱类似物不同，本文所述的碘化化合物可根据碘同位素选择，应用于正电子发射断层扫描，单光子发射计算机断层扫描以及潜在地用于治疗。而且，碘同位素的有利半衰期导致通过同位素交换反应的具有挑战性的合成要少得多。所描述的化合物中有六个是纳摩尔配体，最佳化合物的亲和力比胆碱高100倍。125的生物分布数据用I标记的人类前列腺癌（PC-3）小鼠配体显示了两种化合物，其生物分布特征优于[ 18 F]氟胆碱。
• Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1
  作者：Régis Barattin、Thomas Perrotton、Doriane Trompier、Doriane Lorendeau、Attilio Di Pietro、Amaury du Moulinet d’Hardemare、Hélène Baubichon-Cortay

  DOI：10.1016/j.bmc.2010.07.031

  日期：2010.9

  The multidrug resistance protein 1 (MRP1), involved in multidrug resistance (MDR) of cancer cells, was found to be modulated by verapamil, through stimulation of GSH transport, leading to apoptosis of MRP1-overexpressing cells. In this study, various iodinated derivatives of verapamil were synthesized, including iodination on the B ring, known to be involved in verapamil cardiotoxicity, and assayed for the stimulation of GSH efflux by MRP1. The iodination, for nearly all compounds, led to a higher stimulation of GSH efflux. However, determination of concomitant cytotoxicity is also important for selecting the best compound, which was found to be 10-fold more potent than verapamil. This will then allow us to design original anti-cancer compounds which could specifically kill the resistant cancer cells. (C) 2010 Published by Elsevier Ltd.